Zimbabwe has rejected a substantial US healthcare agreement worth $367m (£272m) over five years due to the United States' demand for confidential information.
This move was revealed following a official document from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official representative has since clarified that the United States was seeking genetic material for research and commercial gain but was unwilling to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further dialogue to secure a deal acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Context
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a high court halted a related deal with the US following concerns were raised about the safety of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral deals to boost openness and responsibility.
Based on statements, 16 African countries have so far signed these new agreements, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to share its genetic material and health information for a long time, without any corresponding guarantee of access to any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," his statement read.
"Effectively, our country would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our population if a future health crisis emerge."
National Interest and Global Health
He also said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining structures previously set up via the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to manage potential global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage continued dialogue with our US partners on how subsequent co-operation might be arranged in a way that honours the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that negotiations should continue since much of the country's HIV programmes were funded by external financing.
"Where technical issues arise, including those involving information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," it added.
The halted deal highlights the complex tensions between receiving crucial foreign assistance and protecting national sovereignty in an increasingly data-driven world.